Why She's Problematic: In the original book that Carol is based on, The Price of Salt, Carol Aird is 32 years old, and her ...

AUSTIN (KXAN) — Former Austin resident KB Brookins, who moved out of Texas in August, on Oct. 4 won the 2025 Lambda Literary Award for Transgender Nonfiction for their 2024 memoir “Pretty.” The book ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X While viewers were expecting the series to wrap up after season 3, Han had a surprise up her ...

Warning: Spoilers ahead for the series finale of “The Summer I Turned Pretty.” Fresh off a series finale and news of a forthcoming movie, “The Summer I Turned Pretty” cast is looking ahead to the next ...

SPOILER ALERT: This post spoils the ending of The Summer I Turned Pretty Season 3. Conrad (Chris Briney) made it to Paris! But Belly (Lola Tung) and Benito (Fernando Cattori) pulled up on their red ...

In the wake of the Minneapolis Catholic church shooting, senior Justice Department officials are weighing proposals to limit transgender people’s right to possess firearms, according to two officials ...

Journalist Jo Ling Kent joined CBS News in July 2023 as the senior business and technology correspondent for CBS News. Kent has more than 15 years of experience covering the intersection of technology ...

At least 2.8 million Americans – including 724,000 in the 13-17 age bracket – identify as transgender, according to a recent analysis of data from federal and state health departments by the ...

Netflix is not developing a sequel to Pretty Woman despite a presumed movie poster making headlines, a source exclusively tells Us Weekly. “This is not happening. It’s fake AI and not true,” a movie ...

Belly and the boys are back. The last installment of "The Summer I Turned Pretty," a coming-of-age romantic television series based on the popular book trilogy by bestselling author Jenny Han, made ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. It’s time to answer the question once and for all: ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY to $119.7M, driven by strong U.S. growth. A subcutaneous version of TGTX's BRIUMVI is in phase 1 trials, with late-stage development ...